New sickle cell disease drug approved for use in England – here’s how voxelotor works
(2024) In The Conversation
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/da8c546c-30e9-4c24-b14e-0e0bee47b3c2
- author
- Flygare, Johan LU
- organization
- publishing date
- 2024-05-09
- type
- Contribution to specialist publication or newspaper
- publication status
- published
- subject
- categories
- Popular Science
- in
- The Conversation
- ISSN
- 2201-5639
- language
- English
- LU publication?
- yes
- id
- da8c546c-30e9-4c24-b14e-0e0bee47b3c2
- alternative location
- https://theconversation.com/new-sickle-cell-disease-drug-approved-for-use-in-england-heres-how-voxelotor-works-229326
- date added to LUP
- 2024-05-13 13:39:17
- date last changed
- 2024-05-13 13:39:17
@misc{da8c546c-30e9-4c24-b14e-0e0bee47b3c2,
author = {{Flygare, Johan}},
issn = {{2201-5639}},
language = {{eng}},
month = {{05}},
series = {{The Conversation}},
title = {{New sickle cell disease drug approved for use in England – here’s how voxelotor works}},
url = {{https://theconversation.com/new-sickle-cell-disease-drug-approved-for-use-in-england-heres-how-voxelotor-works-229326}},
year = {{2024}},
}